Clinical trial
Investigation Of Weight Loss And Body Composition Changes After Dosing With…
NCT00494767 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00494767 |
|---|---|
| Title | Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs |
| Official title | An Exploratory Study to Evaluate Weight Loss, Body Composition Changes, Food Intake and Urine Glucose Excretion in Healthy Obese Subjects Over 8 Weeks of Dosing With GSK189075, GW869682 Versus Placebo |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Obesity |
| Intervention type | Drug |
| Interventions | GW869682, GSK189075, GSK189075-Placebo, GW869682-Placebo |
| Enrollment | 27 |
| Start date | Sep 29, 2006 |
| Primary completion | Jun 7, 2007 |
| Completion | Jun 7, 2007 |
| First posted | Jul 2, 2007 |
| Last update posted | Aug 7, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: